News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors – ASCO
Collage of G Curigliano and Aditya Bardia
Oct 5, 2024, 09:20

DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors – ASCO

ASCO shared a post on X:

“Experts Giuseppe Curigliano & Aditya Bardia discuss the results of the DESTINY-Breast06 trial, which showed significant PFS improvement with T-DXd in pts with HR+, HER2-low metastatic.”

DESTINY-Breast06 Shows Significant PFS Improvement With T-DXd for HR-Positive Metastatic Breast Cancer. How Do These Results Impact Practice for All Patients?

Authors: Giuseppe Curiglian and Aditya Bardia

DESTINY-Breast06 is the first study to investigate a HER2-directed therapy in patients with HER2-ultralow tumors - ASCO

Source: ASCO/X

Aditya Bardia ASCO Breast Cancer cancer cancer awareness cancer care DESTINY-Breast06 fight against cancer Giuseppe Curigliano Global fight against cancer OncoDaily Oncology
Special Coverage
Insight
Dec 25, 2024, 03:51
Maria Babak: Critical advancement in the treatment of mCSCC and laCSCC
Science
Dec 25, 2024, 03:40
The effect of exercise in aiding cancer treatment and mitigating the treatment side-effects, suggested by Christopher Fitzmaurice
Blog
Dec 25, 2024, 03:35
Amol Akhade: Use of Dostarlimab plus niraparib in first line Advanced Ovarian Cancer
Insight
Dec 25, 2024, 03:32
Optimising Cancer Care for Older Adults - MASCC
Insight
Dec 25, 2024, 03:00
Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh
Insight
Dec 25, 2024, 02:57
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Insight
Dec 25, 2024, 02:41
Correlating PSA Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment - European Urology
Science
Dec 25, 2024, 02:35
Hospital Participation in the Acute Hospital Care at Home Waiver Program by Hashem Zikry et al.
Science
Dec 25, 2024, 01:52
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
Blog
Dec 25, 2024, 01:50
Results of SISAQOL-IMI: Advancing Patient-Reported Outcomes Research
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO